**GlucoTrack Announces Resignation of Chief Financial Officer and Appointment of Peter Wulff as Replacement**WASHINGTON, D.C. 2025 – GlucoTrack, Inc. (NASDAQ: GCTK) recently disclosed on January 27, 2025, that James Cardwell, the Chief Financial Offi

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GlucoTrack’s 8K filing here.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.